INTRODUCTION
============

Membrane-associated RING-CH protein 5 (MARCH5) is an E3 ubiquitin ligase located in the mitochondrial outer membrane (with the E3 ligase domain facing the cytoplasm) and is involved in a variety of mitochondrial and cellular processes (for review; [@b25-molce-43-076]). For example, MARCH5 ubiquitylates the mitochondrial outer membrane proteins involved in mitochondrial fusion such as mitofusin 1 (Mfn1), which regulates mitochondrial docking and fusion, and Mfn2, which stabilizes the interactions between mitochondria. Increased expression of Mfn1 in MARCH5-depleted cells enhances mitochondrial fusion but interferes with fission ([@b3-molce-43-076]; [@b30-molce-43-076]; [@b31-molce-43-076]). Ubiquitylation of Mfn2 generates a mitochondrion-associated endoplasmic reticulum membrane domain for Mfn2 oligomerization, enabling Mfn2 proteins to interact and transfer Ca^2+^ from the endoplasmic reticulum to the mitochondrion ([@b7-molce-43-076]; [@b43-molce-43-076]; [@b44-molce-43-076]).

Another target of MARCH5, cytoplasmic dynamin-related protein 1 (Drp1), regulates mitochondrial fission. Drp1 transiently interacts with tetratricopeptide repeats in the outer-membrane-associated protein Fis1 via cytosolic adaptor proteins Mdv1 and Caf4 ([@b18-molce-43-076]; [@b21-molce-43-076]) while MARCH5 counteracts mitochondrial fission by marking Drp1 and Fis1 for degradation ([@b26-molce-43-076]; [@b55-molce-43-076]). MARCH5 also negatively regulates mitochondrial fission via stress-induced degradation of mitochondrial dynamics protein 49 kDa (MiD49) ([@b4-molce-43-076]; [@b54-molce-43-076]). MiD49 is located in the mitochondrial outer membrane and recruits Drp1 to the mitochondrial surface rather than the peroxisomal surface; thus, MiD49 is thought to facilitate Drp1-directed mitochondrial fission ([@b29-molce-43-076]; [@b57-molce-43-076]).

MARCH5 marks mitophagy receptor FUN14 domain-containing protein 1 for degradation in response to hypoxia ([@b53-molce-43-076]). MARCH5 also regulates mitochondrial transport via the degradation of abnormal proteins, such as microtubule-associated protein 1B, which interfere with dynein motor function and block the transport of mitochondria along axonal microtubules ([@b56-molce-43-076]).

Despite the many reports describing the various molecular functions of MARCH5 in mammalian cells, its embryological functions have yet to be described. Therefore, we conducted whole-mount *in situ* hybridization (WISH) and induced ectopic expression and knockdown of *march5* in zebrafish embryos to investigate the role of MARCH5 in vertebrate embryogenesis.

MATERIALS AND METHODS
=====================

Zebrafish care and embryos
--------------------------

Wild-type (WT) zebrafish were obtained from Korea Zebrafish Organogenesis Mutant Bank (ZOMB) and grown at 28.5°C. Embryos were obtained through natural spawning and raised, and staged as described previously ([@b13-molce-43-076]; [@b52-molce-43-076]). Embryonic pigmentation was blocked by treating the embryos with 0.002% phenylthiourea after onset of somitogenesis.

Sequence analysis
-----------------

March5 sequence similarity searches to identify homologous sequences were performed as described previously ([@b12-molce-43-076]) and phylogenic analysis of March5 was conducted at <http://www.treefam.org>.

Molecular cloning
-----------------

Total RNA was isolated from the embryos at various stages using the easy BLUE total RNA extraction Kit (iNtRON Bio, Korea) according to the manufacturer's guidelines. cDNA was synthesized using Superscript III reverse transcriptase (Invitrogen, USA) as described in ([@b17-molce-43-076]). For overexpression studies, the open reading frame (ORF) of *march5* was subcloned into the pcGlobin2 vector between the restriction sites for Xho1 and EcoR1 ([@b36-molce-43-076]).

Morpholino, *in vitro* transcription, and microinjections
---------------------------------------------------------

Splicing-blocking morpholinos (E1/I1: 5′TTTGTTTCTTTCACTTACCTGTCCACG3′) were purchased from Gene-Tools (USA), and dissolved in water. *march5*-specific morpholinos (0.8 to 1 ng) or control morpholinos were injected into zebrafish embryos at the 1-cell stage. *march5* mRNA was synthesized using the Ambion mMESSAGE mMACHINE kit according to the manufacturer's instructions. mRNAs were dissolved in nuclease-free water and diluted in 0.5% phenol red solution for microinjection via a Picopump microinjection device (World Precision Instruments, USA).

Whole-mount *in situ* hybridization (WISH)
------------------------------------------

Embryos were fixed in 4% paraformaldehyde (PFA) overnight, and dehydrated in 100% methanol. Embryos after 24 h post-fertilization (hpf) were digested with 10 μg/ml protease K (Thermo Scientific, USA). WISH was performed with minor modifications as described in ([@b16-molce-43-076]; [@b46-molce-43-076]). Antisense probes of *march5* were synthesized from a specific region within the ORF. Antisense probes of *march5* were synthesized using the DIG RNA Labeling Kit (SP6/T7) (Roche, USA).

Cell culture
------------

HEK293T (human embryonic kidney 293T) cells were obtained from KCLB (Korean Cell Line Bank, Korea) for the Dual-Luciferases assay. HEK 293T cells were cultured in Dulbecco's modified Eagle medium (DMEM; Welgene, Korea) containing 10% fetal bovine serum (FBS; Welgene) and 1% Antibiotic-Antimycotic solution (Gibco, USA).

Luciferase activity assay
-------------------------

Cells were harvested and lysates were collected 24 h post transfection. Firefly and Renilla luciferase activities were measured using a Dual-Luciferase Reporter Assay System (Promega, USA) according to the manufacturer's instructions. Relative luciferase activities are the ratios of the activity of firefly luciferase to that of the Renilla luciferase control.

Reverse transcription-quantitative polymerase chain reaction (RT-qPCR)
----------------------------------------------------------------------

Total RNA from WT and *march5* morpholino injected zebrafish embryos at 4.7 hpf was extracted by RNAiso Plus reagent (TaKaRa Bio, Japan), according to the manufacturer's protocol. The PrimeScript First strand cDNA synthesis kit (TaKaRa Bio) was applied for cDNA generation. qPCR was performed using SYBR-Green qPCR mix (TaKaRa Bio) in a Thermal Cycler Dice Real-Time system TP950 1 Set (TaKaRa Bio). Each assay was performed in triplicate. The specificity of the amplified products was determined by corresponding melting curve analysis. Primers used for RT-qPCR are listed in [Supplementary Table S1](#s1-molce-43-076){ref-type="supplementary-material"}.

Statistical analysis
--------------------

All data are presented as mean ± SD. Statistically significant differences between the two groups were determined using the two-tailed Student's *t*-test. One-way ANOVA was used for comparisons among multiple groups. *P* \< 0.05 was considered to indicate a statistically significant difference. Data analysis were carried out using SPSS 17.0 (IBM, USA).

RESULTS
=======

*march5* is maternally expressed and restricted to the optic vesicles, telencephalon, midbrain, and hindbrain in embryos at 18 hpf
----------------------------------------------------------------------------------------------------------------------------------

To investigate the contribution of *march5* to vertebrate embryogenesis, we examined spatiotemporal expression in zebrafish embryos at various developmental stages. *march5* was expressed both maternally and zygotically because *march5* transcripts were detected by reverse transcriptase polymerase chain reaction (RT-PCR) at the 1-cell stage, and the expression persisted until 24 hpf. WISH confirmed that *march5* is expressed at the 1-cell stage ([Fig. 1A](#f1-molce-43-076){ref-type="fig"}) and revealed evenly distributed transcripts in zygotes at the sphere and shield stages ([Figs. 1B and 1C](#f1-molce-43-076){ref-type="fig"}). *march5* transcripts were localized to the central nervous system at 10 and 12 hpf ([Figs. 1D and 1E](#f1-molce-43-076){ref-type="fig"}) and restricted to the optic vesicles, telencephalon, midbrain, and hindbrain at 18 hpf ([Fig. 1F](#f1-molce-43-076){ref-type="fig"}). This pattern remained at 24 hpf, with *march5* transcripts restricted to the eyes, telencephalon, diencephalon, tegmentum, optic tectum, cerebellum, and rhombomeres ([Figs. 1G and 1H](#f1-molce-43-076){ref-type="fig"}). Thus, *march5* likely contributes to the development of these regions.

Ectopic expression and knockdown of *march5* cause developmental defects in the brain and eyes and dorsoventralization of zebrafish embryos
-------------------------------------------------------------------------------------------------------------------------------------------

Microinjection of *march5* mRNA into zebrafish embryos at the 1-cell stage to induce ectopic expression resulted in notochords that were shorter along the anterior-posterior (A--P) axis but that mediolaterally expanded in comparison to those of control embryos at 24 hpf ([Figs. 2A--2C](#f2-molce-43-076){ref-type="fig"}). Interestingly, repression of *march5* expression in embryos at the 1-cell stage via microinjection of *march5*-specific antisense oligonucleotide morpholinos (*march5* MOs; 0.8 ng per embryo) also resulted in a shortened A--P axis as well as a reduced eye diameter ([Fig. 2F](#f2-molce-43-076){ref-type="fig"}) in comparison to those of 5-mismatch controls ([Fig. 2E](#f2-molce-43-076){ref-type="fig"}) and WT embryos at 24 hpf ([Fig. 2D](#f2-molce-43-076){ref-type="fig"}). We categorized the knockdown defects into three classes on the basis of their severity: class I ([Fig. 2G](#f2-molce-43-076){ref-type="fig"}), embryos with developmental delay but no distinguishable axial defect; class II ([Fig. 2H](#f2-molce-43-076){ref-type="fig"}), embryos with reduced brain volume, poor eye development, and shortened body axis; class III ([Fig. 2I](#f2-molce-43-076){ref-type="fig"}), embryos with truncated head and no discernible axial structure. As shown in [Figure 2K](#f2-molce-43-076){ref-type="fig"}, *march5* MOs increased defects in class II and class III embryos in a dose-dependent manner; when the amount of *march5* MOs per embryo was increased from 0.8 to 1 ng, class I and II defects increased from 37% and 18% to 57% and 35%, respectively.

The defects in the A--P axis of the notochord induced by *march5* MOs (0.8 ng per embryo) were rescued by overexpression of *march5* (100 pg mRNA per embryo); the reduction in brain volume was partially rescued ([Fig. 2J](#f2-molce-43-076){ref-type="fig"}). Together, these data strongly suggest that proper expression of *march5* is critical to the development of the A--P axis, notochord, and brain.

Molecular events associated with the developmental defects induced by *march5* MOs
----------------------------------------------------------------------------------

Cellular rearrangements that reshape the blastoderm into a characteristic vertebrate body plan begin at approximately 4 hpf. At 5 hpf, cells at the margin internalize and form the so-called hypoblast, the precursor of the mesoderm and endoderm ([@b42-molce-43-076]). We thus examined whether an impairment of the normal gastrulation process results in morphological defects, such as a shortened A--P axis in the *march5* morphants at 24 hpf ([Fig. 2H](#f2-molce-43-076){ref-type="fig"}). We conducted WISH analysis of marker genes known to be critical for cell fate specification, including *gsc* and *chd* for the dorsal region, *bmp2b* for the ventral region, and *ntl* for the mesoderm ([@b1-molce-43-076]; [@b8-molce-43-076]; [@b15-molce-43-076]; [@b39-molce-43-076]). Transcript levels of the two dorsal markers, *gsc* and *chd* were remarkably reduced in the dorsal region, accompanying shrinkage of the two gene-expressing domains ([Figs. 3C and 3F](#f3-molce-43-076){ref-type="fig"}) in *march5* morphants at 4.7 hpf when compared with those of WT and the 5′-mismatch control ([Figs. 3A, 3B, 3D, and 3E](#f3-molce-43-076){ref-type="fig"}). In contrast transcripts level of the ventral marker, *bmp2b* was robustly elevated in the ventral region to cause significant expansion of *bmp2b* expressing domain ([Fig. 3I](#f3-molce-43-076){ref-type="fig"}) in *march5* morphants at 4.7 hpf in comparison to those of WT ([Fig. 3G](#f3-molce-43-076){ref-type="fig"}) and the 5′-mismatch control ([Fig. 3H](#f3-molce-43-076){ref-type="fig"}). Furthermore, quantitative studies of *march5* morphants at 4.7 hpf using RT-qPCR showed similar patterns to the spatiotemporal expression patterns of the two dorsal markers, *gsc* and *chd* as well as the ventral marker, *bmp2b* ([Supplementary Fig. S1](#s1-molce-43-076){ref-type="supplementary-material"}). These results suggest that March5 contributes to dorsalizing process in zebrafish embryos. It is thus conceivable that proper spatiotemporal expression of *march5* is essential for formation of the normal dorsoventral axis in zebrafish embryos.

*march5* contributes to convergent extension (CE)
-------------------------------------------------

During gastrulation, CE of both ectodermal and mesendodermal cells leads to mediolateral narrowing and A--P extension of the emerging embryonic body axis ([@b42-molce-43-076]). At the shield stage, cells deep underneath the superficial noninvoluting endocytic marginal (NEM) cell domain involute to form the nascent hypoblast of the embryonic shield, whereas cells within the NEM cell cluster form a loose mass of forerunner cells in front of the blastoderm margin ([@b6-molce-43-076]). To examine if MARCH5 is essential for CE, we first analyzed the expression pattern of *ntl*, a marker of mesendodermal cells in zebrafish embryos with ectopic expression or knockdown of *march5*. For ectopic expression, 50 pg *march5* mRNA was injected into embryos at the 1- to 2-cell stage. WISH for *ntl* revealed that overexpression of *march5* hindered extension of posterior paraxial mesendodermal cells, resulting in a shorter A--P axis and mediolateral expansion at 8 hpf ([Fig. 4B](#f4-molce-43-076){ref-type="fig"}) in comparison to that in the control ([Fig. 4A](#f4-molce-43-076){ref-type="fig"}). By contrast, knockdown of *march5* generated a partial axial mesendoderm, which left the posterior region separated at 8 hpf ([Fig. 4D](#f4-molce-43-076){ref-type="fig"}), rather than a complete axial mesoderm, as seen in the controls ([Figs. 4A and 4C](#f4-molce-43-076){ref-type="fig"}).

The nascent hypoblast formed during involution then moves toward the animal pole ([@b48-molce-43-076]), and at 60% epiboly, the dorsal forerunner cells (DFCs) develop at the leading edge of the blastoderm ([@b6-molce-43-076]). To examine if the defective involution of the axial hypoblast disrupts the formation of DFCs in zebrafish embryos, we studied the expression pattern of the marker gene *sox17*. At 8 hpf, *sox17* expression in control embryos revealed the migration of DFCs toward the posterior region in front of the advancing blastoderm margin ([Fig. 4E](#f4-molce-43-076){ref-type="fig"}). However, these DFCs were dispersed in embryos overexpressing *march5* ([Fig. 4F](#f4-molce-43-076){ref-type="fig"}). By contrast, knockdown of *march5* substantially reduced the area of *sox17* expression ([Fig. 4H](#f4-molce-43-076){ref-type="fig"}). In addition, the development of Kupffer's vesicle was severely retarded in *march5* morphants after gastrulation (data not shown). These data suggest that *march5* regulates the movement of the hypoblast to initiate DFC formation at the blastoderm margin during gastrulation in zebrafish embryos ([Supplementary Fig. S2](#s1-molce-43-076){ref-type="supplementary-material"}).

*march5* controls patterning of the forebrain and hindbrain fields during gastrulation
--------------------------------------------------------------------------------------

We next examined the embryological consequences of *march5* overexpression and knockdown on brain development. Specifically, two-color WISH was performed at 10 and 18 hpf for *fgf8* and *krox20*, markers of the midbrain--hindbrain boundary, hindbrain, and rhombomere ([@b28-molce-43-076]; [@b35-molce-43-076]). The analysis demonstrated that the distance between the midbrain--hindbrain boundary (marked by an asterisk in [Fig. 5C](#f5-molce-43-076){ref-type="fig"}) and rhombomere 3 was shortened along the A--P axis by approximately 3-fold in *march5* morphants in comparison to those of WT and 5-mismatch MO controls ([Figs. 5A and 5B](#f5-molce-43-076){ref-type="fig"}) at 18 hpf. These results imply that the retarded CE in *march5* morphants results in the abnormal patterning of the corresponding developing brain subdomains.

We then characterized anterior neural plate development between 10 and 24 hpf by performing WISH for *rx3* and *emx3*, markers of the telencephalon ([@b5-molce-43-076]; [@b19-molce-43-076]; [@b22-molce-43-076]; [@b50-molce-43-076]). *rx3* transcripts were substantially reduced in the presumptive anterior forebrains of *march5* morphants at 10 hpf ([Fig. 5F](#f5-molce-43-076){ref-type="fig"}) in comparison to those of WT and 5-mismatch MO controls ([Figs. 5D and 5E](#f5-molce-43-076){ref-type="fig"}). The near elimination of *emx3* at 24 hpf in the ventral forebrain of embryos with *march5* knockdown ([Fig. 5I](#f5-molce-43-076){ref-type="fig"}) suggests that *march5* contributes to the specification of anterior forebrain precursors during gastrulation ([Supplementary Fig. S3](#s1-molce-43-076){ref-type="supplementary-material"}). However, *emx3* expression was only slightly decreased in the telencephalic regions of *march5* morphants in comparison to those of WT and 5-mismatch MO controls ([Figs. 5G and 5H](#f5-molce-43-076){ref-type="fig"}). Altogether, these data suggest that proper *march5* expression is essential for appropriate patterning of the telencephalon.

Transcriptional factors Znf143a and Znf76 regulate *march5* expression in 293T cells
------------------------------------------------------------------------------------

We next examined the regulatory region of *march5* for the presence of *cis*-acting elements conferring transcriptional activity. Specifically, nucleotide sequences in the zebrafish *march5* promoter located between −2917 and +296 bp of the transcriptional start site were targeted because this region contains three putative binding sites for Staf (selenocysteine tRNA gene transcription-activating factor), C/EBPα (CCAAT enhancer binding protein alpha), and CHOP (C/EBP homologous protein):C/EBPα (shown in [Fig. 6A](#f6-molce-43-076){ref-type="fig"}). To measure the transcriptional activities of these three *cis*-acting elements, we generated four *march5*-*luc* reporter constructs lacking the binding sites for Staf, C/EBPα, and/or CHOP:C/EBPα ([Fig. 6A](#f6-molce-43-076){ref-type="fig"}), and expressed them in human embryonic kidney cells (HEK 293T cells). Transcriptional activities of the three reporter constructs containing 1.7 kb, 2.4 kb, or 2.9 kb regions were 2-, 3.5-, 4-fold higher that of the reporter containing the 0.8 kb region ([Fig. 6B](#f6-molce-43-076){ref-type="fig"}). The reporter construct containing the 1.7 kb region was chosen because it contains most of the *cis*- and *trans*-acting elements, such as Staf, CHOP, and C/EBPα.

To determine if CHOP and C/EBPα transcriptionally regulate *march5*, we measured the luciferase activities of the constructs with or without CHOP and/or C/EBPα in the 1.7 kb-long region. As shown in [Figure 6C](#f6-molce-43-076){ref-type="fig"}, deletion of the binding site for CHOP did not alter the transcriptional activity of the 1.7 kb-long region, whereas deletion of the binding sites for both CHOP and C/EBPα dramatically increased the luciferase activity by more than 5-fold relative to that of the control reporter construct containing both elements. However, deletion of the Staf binding site in addition to the CHOP:C/EBPα sites abolished transcriptional activity, observed as a complete loss of luciferase activity. Taken together, these results demonstrate that Staf functions as a potent transcriptional activator and that CHOP and C/EBPα act as transcriptional repressors of *march5*. Expression of these three transcriptional regulators may thus coordinate transcription of *march5* in zebrafish embryos.

There is notable homology between Staf and the human proteins ZNF76 and ZNF143 ([@b11-molce-43-076]; [@b32-molce-43-076]; [@b47-molce-43-076]), which both contain domains similar to the Staf transactivation domains that stimulate transcription from RNA polymerase II (PolII) and PolIII small nuclear RNA (snRNA)-type promoters as well as PolII TATA box-containing mRNA promoters ([@b24-molce-43-076]; [@b38-molce-43-076]). The high degree of sequence conservation between the zinc finger regions in *znf76* and *znf143* in the zebrafish indicate that both proteins may recognize the same Staf motif within the *march5* promoter. Luciferase activity from HEK 293T cells co-transfected with plasmids harboring the *march5* promoter and those encoding Znf143a or Znf76 was increased 3-fold, and luciferase activity was increased 4-fold when cells expressed the *march5* promoter and both Znf143a and Znf76 ([Fig. 6D](#f6-molce-43-076){ref-type="fig"}). Thus, we postulate that *march5* is transcriptionally regulated in a finely tuned manner by CHOP, C/EBPα, Staf, Znf143a, and Znf76.

DISCUSSION
==========

MARCH5 is a mitochondrial ubiquitin ligase that regulates mitochondrial integrity and cellular protein homeostasis via the ubiquitin proteasome system ([@b25-molce-43-076]). We demonstrate here that March5 also regulates vertebrate embryogenesis because either knockdown or ectopic expression of *march5* in zebrafish embryos retarded CE at 8 hpf, resulting in defective development of the ventral diencephalon, midbrain, and midbrain--hindbrain boundary at 24 hpf.

Beginning at 4.3 hpf, cells intercalate radially, contributing to epiboly, while cells at the margins migrate toward the animal pole to form the hypoblast. The various progenitor territories at 6 hpf are not sharply demarcated in the fate maps of zebrafish embryos ([@b14-molce-43-076]; [@b41-molce-43-076]). We thus examined the expression of morphogenetic markers at pre-gastrulation and gastrulation stages. We found that at 4.7 hpf, knockdown of *march5* reduced the expression of the dorsal markers but increased the expression of the ventral markers. In zebrafish, the fates of dorsal cells at the shield were once thought to be regulated by inducers expressed by the organizer; however, it is now known that the organizer represses factors secreted from ventral regions of the embryos ([@b27-molce-43-076]), such as bone morphogenetic protein (BMP), Wnt, and Nodal family proteins; For example, ventrally expressed Wnt8 restricts the size of the zebrafish organizer in the late blastula/early gastrula by regulating the expression of the transcriptional repressors Vox and Vent, whereas during late gastrulation, the expression of these genes is maintained by BMP signaling ([@b34-molce-43-076]; [@b33-molce-43-076]). In the absence of secreted BMP antagonists, Gsc has *chd*-independent functions in dorsoventral patterning and elicits complete secondary axes ([@b9-molce-43-076]). We also found that *march5* knockdown not only changed level of *wnt8* transcripts ([Supplementary Fig. S4](#s1-molce-43-076){ref-type="supplementary-material"}) but also reduced the transcript levels of *gsc* and *chd* ([Figs. 3C and 3F](#f3-molce-43-076){ref-type="fig"}).

We demonstrated that *march5* was transcriptionally regulated at CHOP and C/EBP binding sites. CHOP is a developmentally regulated nuclear protein that inhibits *wnt8*-mediated dorsal development in *Xenopus* embryos ([@b10-molce-43-076]). However, CHOP also dimerizes with C/EBP via its leucine zipper domain to function as a dominant negative inhibitor of gene transcription ([@b37-molce-43-076]), arresting growth and inducing apoptosis under conditions of endoplasmic reticulum stress or DNA damage ([@b20-molce-43-076]; [@b45-molce-43-076]; [@b49-molce-43-076]; [@b51-molce-43-076]; [@b58-molce-43-076]). Thus, CHOP and C/EBPα may work similarly to represses *march5* transcription. By contrast, we found that the binding of Znf76 and Znf143 to the Staf site in the proximal promoter of *march5* may induce transcription. Staf, a transcriptional activator originally identified in *Xenopus laevis*, enhances the transcription of snRNA and snRNA-type genes via Pol II and Pol III ([@b23-molce-43-076]; [@b40-molce-43-076]). The Staf binding site may be a regulator of organ-specific transcription because transgenic mice expressing a *Trsp* (selenocysteine tRNA gene) transgene lacking the Staf binding site had an \~80% reduction in the levels of Sec tRNA in the brain and muscle but unaltered or elevated levels in other tissues ([@b2-molce-43-076]). We found that *march5* transcription in zebrafish embryos was regulated by Znf76 and Znf143, which bind with similar affinities to Staf responsive elements ([@b24-molce-43-076]). It is thus most probable that Znf76 and Znf143, together with C/EBPα and CHOP, modulate *march5* transcription to regulate biological processes such as vertebrate embryogenesis.

The data presented here provide insight into the functions of a mitochondrial ubiquitin ligase during vertebrate embryogenesis. We found that expression of *march5* must be tightly regulated for proper gastrulation and CE in zebrafish embryos. Our data indicate that Znf76 and Znf143 bind to the Staf region in the *march5* promoter and modulate C/EBPα:CHOP regulation of *march5* transcription. This is the first report to show that March5 affects the functional connection between convergence and extension processes during gastrulation. The newly identified cis- and trans-regulatory elements provide new insights into the molecular mechanisms of *march5* specific transcriptional networks in zebrafish.
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![Spatiotemporal expression patterns of zebrafish *march5*\
WISH analysis of *march5* at 1 cell through 24 hpf. (A) *march5* was expressed in the blastodisc at 1-cell stage, indicating it is maternally expressed. (B) After MBT (512-cell), *march5* was expressed in deep cell layer (DEL) and enveloping layer (EVL) except I-YSL (yolk syncytial layer). (C) *march5* was expressed in both ventral & dorsal region at shield stage. (D--F) The transcripts were abundant in the central nervous system at 10 hpf through 18 hpf. (F) At 18 somite, *march5* transcripts were distributed in the precursor region of brain along the AP axis. (G and H) *march5* expression patterns at 24 hpf zebrafish embryo stage. Lateral (G) and anterior view (H) of the embryos labeled with *march5* antisense probe at 24 hpf. *march5* was expressed in the forebrain through the notochord including the telencephalon, diencephalon, tegmentum, optic tectum, cerebellum and rhombomere. All embryos were collected synchronously from WT zebrafish for WISH analysis at the corresponding stages. MHB, midbrain hindbrain boundary; ot, optic tectum; c, cerebellum; rh, rhombomere; te, tegmentum; hb, hindbrain; m, midbrain; d, diencephalon; t, telencephalon. (A--H) Scale bars = 250 μm.](molce-43-076f1){#f1-molce-43-076}

![Overexpression and knockdown of *march5* in zebrafish embryos\
(A) WT zebrafish embryo, (B) vehicle control injected with the same volume of phenol red dye in distilled water as the volume of the mRNAs injected, and (C) *march5* mRNA injected embryo. Microinjection of *march5* mRNA (50 pg) into embryos at 1-cell stage for overexpression of *march5*. (D) WT, (E) 5-mismatch MO, and (F) *march5* MO that 0.8 ng of *march5* morpholino was injected into embryos at 1-cell stage for knockdown of *march5*. (G--J) At 24 hpf, embryos injected with *march5* MO and coinjected with *march5*-MO and *march5* mRNA. (G--I) *march5* morphants are categorized as Class 1 through 3. (J) Rescue with *march5* mRNA after injection of *march5*-MO. (K) The proportion of normal appearing embryos (C1) is increased after recue with *march5* mRNA. (A--J) Scale bars = 250 μm.](molce-43-076f2){#f2-molce-43-076}

![Knock-down of *march5* expression alters dorso-ventral patterning at 4.7 hpf\
(A--F) WISH analysis of *march5* in dorso-ventral axis development using dorsal markers, *gsc* and *chd* at 4.7 hpf. WT embryos (A and D), embryos injected with 5-mismatch as control (B and E), and *march5* MO (C and F). *march5* morphants showed narrower and reduced expression pattern for *gsc* (C) and the level of *chd* transcripts was significantly reduced in the dorsal region (D--F). (G--I) Embryos were examined for the expression of ventral marker, *bmp2b* at 4.7 hpf. Transcripts of *bmp2b* in WT (G) and 5-mis MO control (H). Injection of *march5*-MO caused notable expanded *bmp2b* expression domains, circumference around the germ ring region at 4.7 hpf (I). (A--I) Scale bars = 200 μm.](molce-43-076f3){#f3-molce-43-076}

![Knock-down of *march5* expression causes changes in expression patterns of the molecular markers, *ntl* and *sox17* at 8 hpf\
(A--D) WISH analysis using *ntl* as a molecular marker for the convergence and extension (C&E) indicates that loss of *march5* function disrupted the processes in C&E governing anterior-posterior patterning. (A) WT embryo. Microinjection of *march5* mRNA (50 pg per embryo) into wild-type embryos thickened the C&E (B). *march5* 5-mismatch control embryos had the similar expression patterns in C&E (C) to that of WT (A). In contrast, knock-down of *march5* (0.8 ng morpholino per embryo) splited the body axis (arrowheads) in *march5* morphants at 8 hpf (D). (E--H) WISH analysis with *sox17* as a molecular marker for the DFCs. *sox17* transcripts were present in the DFC of WT (E) and control embryos injected with 5-mismatch (G). Overexpression of *march5* (*march5* mRNA 50 pg per embryo) extended the area expressing *sox17* (F) while knock-down of *march5* (0.8 ng of *march5* morpholino per embryo) remarkably reduced the level of *sox17* transcripts in the DFC (asterisk) of the morphants (H). (A--H) Scale bars = 200 μm.](molce-43-076f4){#f4-molce-43-076}

![*march5* knock-down reduced expression of *rx3* and *emx3* in zebrafish embryos\
(A--C) Two color WISH analysis with *krox20*- and *fgf8*-specific probes detected changes in their transcripts in the MHB (asterisks) and the hindbrain, the rhombomeres (r) 3 and 5 at 18 hpf. (A) WT embryo, (B) 5-mismatch MO control, and (C) *march5* MO (0.8 ng of *march5* morpholino per embryo). (D--I) WISH analysis of *march5* MO (0.8 ng of *march5* morpholino per embryo) using *rx3* and *emx1* as probes. (D) *rx3* transcripts in the presumptive eye field and hypothalamus of WT embryos at 10 hpf. (E) Embryos injected with 5-mismatch showed similar patterns to those of WT embryos. (F) *march5* MO shows remarkable reduction of *rx3* transcripts in the presumptive eye field and hypothalamus, which abut the telencephalic primordium at 10 hpf. Transcripts of *emx3* in WT (G), 5-mismatch control (H), and *march5* MO (I) at 24 hpf. *emx3* transcripts were present in the telencephalon and ventral diencephalon in WT and 5-mismatch control whereas the ventral diencephalon expression was lost in the corresponding areas of *march5* MO. vd, ventral diencephalon; t, telencephalon. (A--I) Scale bars = 100 μm.](molce-43-076f5){#f5-molce-43-076}

![Znf143a and Znf76 modulate *march5* expression\
(A) Schematic representation of zebrafish *march5* genomic region and reporter construct. Six exons (EX1 to EX6) and five introns are depicted; the translation initiation site is indicated with an arrow. The firefly luciferase (*luc*) coding region was fused with the zebrafish *march5* promoter (−2904 to +296 bp). (B--D) Luciferase activity under the control of the *march5* regulatory regions. (B) Luciferase activity of a transiently transfected *march5*-*luc* reporter in 293T cells (\**P* \< 0.05 vs Con, as determined by Student's *t*-test). (C) Deletion analysis of the zebrafish *march5* promoter. Cells were transfected with the Staf, CHOP and CHOP:C/EBPα-deletion promoter-luciferase reporter plasmids. A significant difference between 1.7 kb and 1.7 kbΔCHOP, C/EBPα (\*\**P* \< 0.01, as determined by Student's *t*-test). (D) Effects of Znf143a and Znf76 proteins on the zebrafish *march5* promoter activation. Cells were co-transfected with Znf143a and Znf76 expression plasmid (empty pc2+ expression plasmid as control), and Pgl3 promoter-luciferase reporter plasmids fused with the zebrafish *march5* promoter (0.8 kb and 1.7 kb). Luciferase activity of *march5* promoter in 293T cells is expressed as normalized luciferase activity (to *Renilla* luciferase activity) relative to empty Pgl3-Basic plasmid (\**P* \< 0.05, \*\**P* \< 0.01 vs 1.7kb, as determined by Student's t-test).](molce-43-076f6){#f6-molce-43-076}
